PDE3A and hypertrophic cardiomyopathy 1: In the current study, we investigated the effects of PDE3A pathway modulation in two mouse models of CMH: the inflammation-induced mouse model and the amyloid precursor protein transgenic mouse model that develops CAA and spontaneous CMH.